Setup News Ticker
Searching for 'COVID-19 million'. (Return)

Yahoo BusinessSep 24, 2020
Novavax Shares Surge 7% As It Begins Late-Stage COVID-19 Vaccine Trials
Novavax, Inc (NASDAQ: NVAX) said Thursday it was launching a large-scale diverse Phase 3 study of its COVID-19 vaccine in the United Kingdom -- causing a more than 7% spike in the company's shares after the closing bell.What Happened: The study will enroll up to 100,000 individuals, aged between 18-84 years of age, with and without relevant comorbidities, Novavax said in a statement.The drugmaker said that the trial is being conducted in partnership with the U.K. government's Vaccines Taskforce and will last over the next four to six weeks.The Maryland-based drugmaker will enroll at least 25% of participants over the age of 65 to prioritize groups it said were most affected by COVID-19, which includes racial and ethnic minorities.Why It Matters: Novavax said it has secured $2 billion in funding for its worldwide vaccine program, which includes $388 million from the Coalition for Epidemic Preparedness Innovations, co-founded by the Bill & Melinda Gates Foundation.Earlier this month, another beneficiary of the Gates Foundation, Pfizer Inc (NYSE: PFE) said participants in its late-stage study only showed mild-to-moderate side effects.Pfizer and Moderna Inc's (NASDAQ: MRNA) vaccines may be the first to be distributed in late October or November in the United States, according to the New York Times.Meanwhile, AstraZeneca plc's (NYSE: AZN) vaccine trials have yet to resume in the U.S., after being halted due to an adverse reaction earlier, leading to scientists questioning the suspension of the trial.
Coronaviruslatest vaccine cases Democrats bill
Pandemicduring Sales Asia fresh stocks
StocksEuropean Buy Asia Futures Market
StockMarket Buy Today Futures Markets
COVID-19vaccine trial Amid UK United
TrumpBiden election vaccine How CNN
Amazondrone gaming Echo Ring Luna
Chinarichest bottled water FTSE global
earningsCall Transcript Q4 Q2 Costco

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News Analysis Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News - China, Economy & Trade - Financial Markets - Hedge Funds - Telecoms - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC